QIAGEN N.V. logo
QIAGEN N.V. QGEN
report update icon

Annual report 2025
added 04-18-2026

QIAGEN N.V. Gross Profit | QGEN

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit QIAGEN N.V.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.3 B 967 M 1.23 B 1.38 B 1.45 B 1.23 B 1.01 B 1 B 923 M 845 M 826 M 865 M 815 M 824 M 750 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.45 B 750 M 1.03 B

Gross Profit of other stocks in the Diagnostics research industry

Issuer Gross Profit Price % 24h Market Cap Country
Heska Corporation Heska Corporation
HSKA
111 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
4.56 M - -20.0 % $ 1.06 M usaUSA
Syneos Health Syneos Health
SYNH
4.42 B - - $ 4.46 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
-398 K - -34.28 % $ 263 K israelIsrael
Renalytix AI plc Renalytix AI plc
RNLX
156 K - 5.66 % $ 22.7 M britainBritain
Chembio Diagnostics Chembio Diagnostics
CEMI
6.58 M - 0.22 % $ 16.8 M usaUSA
Psychemedics Corporation Psychemedics Corporation
PMD
7.1 M - -1.84 % $ 15.3 M usaUSA
Quotient Limited Quotient Limited
QTNT
14.9 M - -11.32 % $ 1.1 M schweizSchweiz
T2 Biosystems T2 Biosystems
TTOO
-3.15 M - -39.35 % $ 313 K usaUSA
DermTech DermTech
DMTK
276 K - -11.32 % $ 2.94 M usaUSA
Bioventus Bioventus
BVS
388 M $ 13.0 1.39 % $ 866 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
12.7 M $ 6.75 2.31 % $ 26.9 M israelIsrael
Akumin Akumin
AKU
53.5 M - -17.87 % $ 25.9 M canadaCanada
Accelerate Diagnostics Accelerate Diagnostics
AXDX
2.7 M - -61.36 % $ 2.46 M usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
83.8 K $ 2.69 1.45 % $ 87.3 K usaUSA
Biocept Biocept
BIOC
6.12 M - -13.05 % $ 7.29 M usaUSA
Biodesix Biodesix
BDSX
18.5 M $ 27.7 1.09 % $ 209 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
2.77 M $ 1.56 17.29 % $ 8.49 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
403 M $ 11.68 0.69 % $ 123 M chinaChina
CareDx, Inc CareDx, Inc
CDNA
81.6 M $ 52.64 0.52 % $ 2.81 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
400 K $ 1.14 2.7 % $ 1.52 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
958 M $ 272.88 0.59 % $ 13.5 B usaUSA
Castle Biosciences Castle Biosciences
CSTL
53 M $ 35.5 6.16 % $ 1.03 B usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
2.69 B $ 247.08 3.9 % $ 27.4 B usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
188 M - - $ 1.49 B usaUSA
Biomerica Biomerica
BMRA
362 K $ 2.3 0.42 % $ 6.7 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
131 M $ 21.28 3.05 % $ 655 M usaUSA
Guardant Health Guardant Health
GH
144 M $ 175.65 4.65 % $ 22 B usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
817 M $ 172.45 2.08 % $ 13.5 B irlandaIrlanda
IDEXX Laboratories IDEXX Laboratories
IDXX
2.66 B $ 510.73 0.23 % $ 41.1 B usaUSA
Danaher Corporation Danaher Corporation
DHR
14.5 B $ 209.36 3.01 % $ 149 B usaUSA
Illumina Illumina
ILMN
2.87 B $ 222.29 6.76 % $ 34.5 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
3.79 B $ 269.67 1.51 % $ 46.4 B usaUSA
Brainsway Ltd. Brainsway Ltd.
BWAY
30.6 M $ 13.46 0.14 % $ 457 M israelIsrael
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
4.01 B $ 323.97 2.75 % $ 27 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
942 M $ 100.73 0.41 % $ 6.8 B usaUSA
DexCom DexCom
DXCM
2.8 B $ 86.45 2.09 % $ 33.7 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
246 M $ 620.48 4.21 % $ 17.9 B usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
2.39 B $ 1 330.4 3.47 % $ 27.4 B schweizSchweiz
Myriad Genetics Myriad Genetics
MYGN
577 M $ 3.88 2.37 % $ 359 M usaUSA
ENDRA Life Sciences ENDRA Life Sciences
NDRA
6.17 K $ 5.66 1.13 % $ 4.45 M usaUSA
NeoGenomics NeoGenomics
NEO
314 M $ 18.89 2.61 % $ 2.42 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
408 M $ 12.25 2.51 % $ 2.66 B usaUSA
National Research Corporation National Research Corporation
NRC
81.5 M $ 21.96 5.63 % $ 492 M usaUSA
Natera Natera
NTRA
127 M $ 350.78 2.63 % $ 48 B usaUSA
OPKO Health OPKO Health
OPK
206 M $ 1.57 0.64 % $ 1.18 B usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
45.8 M $ 1.34 0.37 % $ 402 M usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
8.06 B $ 24.9 1.99 % $ 23.6 B niderlandNiderland
Personalis Personalis
PSNL
22.1 M $ 16.1 0.31 % $ 1.44 B usaUSA